MDXH vs. ATNFW, SXTPW, ACONW, AIMDW, DRTSW, ALVOW, AONCW, AONC, APLMW, and ARTLW
Should you be buying MDxHealth stock or one of its competitors? The main competitors of MDxHealth include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Aclarion (ACONW), Ainos (AIMDW), Alpha Tau Medical (DRTSW), Alvotech (ALVOW), American Oncology Network (AONCW), American Oncology Network (AONC), Apollomics (APLMW), and Artelo Biosciences (ARTLW). These companies are all part of the "medical" sector.
MDxHealth (NASDAQ:MDXH) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, media sentiment, community ranking, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.
MDxHealth received 13 more outperform votes than 180 Life Sciences when rated by MarketBeat users.
180 Life Sciences has lower revenue, but higher earnings than MDxHealth.
MDxHealth presently has a consensus price target of $28.33, indicating a potential upside of 877.01%. Given MDxHealth's higher possible upside, equities analysts clearly believe MDxHealth is more favorable than 180 Life Sciences.
In the previous week, 180 Life Sciences had 1 more articles in the media than MDxHealth. MarketBeat recorded 2 mentions for 180 Life Sciences and 1 mentions for MDxHealth. 180 Life Sciences' average media sentiment score of 1.88 beat MDxHealth's score of 0.94 indicating that 180 Life Sciences is being referred to more favorably in the news media.
Summary
MDxHealth beats 180 Life Sciences on 4 of the 6 factors compared between the two stocks.
Get MDxHealth News Delivered to You Automatically
Sign up to receive the latest news and ratings for MDXH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MDXH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
MDxHealth Competitors List
Related Companies and Tools
